Cinotaz 2 g or 4 g Powder for solution for infusion
PDF Leaflet Revision Date: 04 Feb 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of systemic and local bacterial infections.
Dosage (summary)
Adults: CINOTAZ 4 (4/0.5 g) every 8 hours; Neutropenic patients: every 6 hours.
Special Populations
- Elderly
- Renal impairment
Pregnancy & Breastfeeding
Crosses placenta; not recommended during breastfeeding.
Key Drug Interactions
- Probenecid
- Vancomycin
- Oral anticoagulants
- Non-depolarising muscle relaxants
- Methotrexate
Contraindications
- Hypersensitivity to piperacillin or tazobactam
- History of allergic reactions to penicillins or cephalosporins
Common side effects
- Diarrhoea
- Nausea
- Vomiting
- Rash
- Fever
Counselling Points
- Monitor for allergic reactions
- Report severe diarrhoea
- Avoid mixing with aminoglycosides in IV solutions
Serious warnings
- Haemophagocytic lymphohistiocytosis
- Serious hypersensitivity reactions
- Pseudomembranous colitis
Important Disclaimer
The Cinotaz 2 g or 4 g Powder for solution for infusion professional information leaflet below is the property of Biotech Laboratories and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
